The Myelodysplastic Syndrome Clinical Research Consortium is recruiting patients for a study of MDS patients who have not responded to Vidaza or Dacogen, or who have stopped responding.
Study participants will have blood drawn for the study at the time of their routine local doctor visit, at no cost. The study is being run at Weill Cornell Medicine (NewYork-Presbyterian), where MDS expert Dr. Gail Roboz works.
Details and links are at the
CRUSH!!MDS website.